DiaMedica Therapeutics
DMAC
DMAC
56 hedge funds and large institutions have $33.5M invested in DiaMedica Therapeutics in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 18 increasing their positions, 4 reducing their positions, and 21 closing their positions.
Holders
56
Holders Change
-1
Holders Change %
-1.75%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
21
Increased
18
Reduced
4
Closed
21
Calls
$8K
Puts
$1K
Net Calls
+$7K
Net Calls Change
-$41K
Top Buyers
| 1 |
1
BlackRock
New York
|
$4.65M |
| 2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$2.46M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$5.99M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$983K |
| 5 |
5
Northern Trust
Chicago,
Illinois
|
$1.27M |
Top Sellers
| 1 |
1
Millennium Management
New York
|
$0 |
| 2 |
2
Goldman Sachs
New York
|
$69.8K |
| 3 |
3
Jane Street
New York
|
$0 |
| 4 |
4
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$300K |
| 5 |
HF
5
HRT Financial
New York
|
$0 |
